Citigroup Issues 'Buy' on ICBC Citing ¥100B Injection Plan

Edgen Stock

·Mar 30 2026, 07:56

Share to

Share to

Copy link

Key Takeaways

Citigroup reaffirmed its confidence in Industrial and Commercial Bank of China (ICBC), issuing a 'Buy' rating despite fourth-quarter results that slightly trailed expectations. The bank's bullish outlook is primarily driven by an anticipated large-scale capital injection from a state-backed entity, which is expected to fortify the bank's balance sheet and support its valuation.

Citigroup set a 'Buy' rating for ICBC with a target price of HK$7.95, signaling strong institutional support.
A ¥100 billion capital injection from Central Huijin Investment is expected, which underpins the positive rating.
Despite a slight earnings miss and 0.7% annual profit growth, ICBC's valuation remains attractive at a projected 2026 price-to-book ratio of 0.52x.

Citi Backs ICBC With HK$7.95 Target on Planned ¥100B Injection

On March 30, 2026, Citigroup issued a research report reiterating a "Buy" rating for the Industrial and Commercial Bank of China (ICBC: 01398) and setting a price target of HK$7.95. The core of this optimistic forecast is the expected capital injection of approximately 100 billion RMB from Central Huijin Investment. Citigroup analysts project this move will strengthen ICBC's capital base significantly. While the capital increase could cause a 3% to 4% dilution to earnings per share, analysts believe the strategic benefits far outweigh this modest impact, solidifying the bank's financial foundation.

Valuation Holds Appeal Despite 0.7% Profit Growth

ICBC's full-year results for 2025 showed a net profit increase of 0.7% to 368.6 billion RMB, with pre-provision profit rising 1.9% to 5,545 billion RMB, figures that were slightly below Citigroup's forecasts. The fourth quarter revealed a slowdown in net profit growth to 1.9%, down from 3.3% in the third quarter, largely because of increased credit costs. However, even after factoring in the potential share dilution, Citigroup highlights the bank's compelling valuation. ICBC's H-shares trade at a projected 2026 price-to-book ratio of just 0.52x, coupled with an estimated dividend yield of 5.2%, presenting an attractive entry point for investors.